Hologic Stock News

Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Hologic (NASDAQ: HOLX) stock price has staged a strong recovery in November after the company pointed to post-Covid-19 growth. The shares jumped to a high of $72.95, which was modestly higher than the

Private-equity firm KKR & Co. Inc. KKR, +7.73%, Hologic Inc. HOLX, +1.04% are teaming up to create a new platform aimed at accelerating innovation in medical technology with an initial focus on lung c

Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Today, we take a deeper look at diagnostic and medical device concern, Hologic, Inc., whose stock has made a nice run here in November. The company is seeing impressive growth from some of its core di

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, Novembe

Since market valuations are always changing, along with outlooks for corporate revenue and earnings, any list of favored stocks is only a snapshot. Repeating the same analysis in the near term might l

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

U.S. equities rallied Friday to post solid gains, with the S&P 500 adding 1.6% and the Nasdaq soaring 2%. The market powered ahead as bond yields pulled back from their jump Thursday when Fed Chair Je

Steve MacMillan, Hologic CFO, joins 'Squawk on the Street' to discuss key tailwinds Hologic is seeing, strategic use cases for the company's cash, and playbooks for weight-loss drugs.

U.S. equities gained at midday after yesterday's selloff snapped long winning streaks for the S&P 500 and Nasdaq. Bond yields were lower after jumping yesterday when Fed Chair Jerome Powell suggested

Hologic, Inc. (NASDAQ:HOLX ) Q4 2023 Earnings Call Transcript November 9, 2023 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President a

While the top- and bottom-line numbers for Hologic (HOLX) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compa

Hologic on Thursday reported fourth-quarter sales that beat Wall Street estimates on strong demand in its breast health segment, sending the medtech firm's shares up 2.7% in extended trading.

Besides Wall Street's top -and-bottom-line estimates for Hologic (HOLX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu